ConditionMigraine
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-85
SponsorTexas Tech University Health Sciences Center, El Paso
About this trial
For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.
Eligibility criteria
Qualifiers
Meet ICHD-3 Migraine Headache Criteria
Had a minimum 5-point reduction in headache intensity after nerve block(s) or post- block pain score of 0 to 2
Nerve block performed with bupivacaine 0.5%
Disqualifiers
Head trauma
Suspicion of secondary headache (i.e. stroke, known tumor, glaucoma)
Headache in the setting of viral syndrome
Chronically on steroids
Trial design
Treatments tested in this trial
- Dexamethasone Oral
- Placebo
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov